Tencent Medical AI Partners with UK's Medopad to Launch International Clinical AI Solutions
VCBeat has learned that Tencent recently announced a strategic cooperation intention between its medical AI laboratory and the UK-based mobile health company Medopad,Both partiesJointly research the clinical application of artificial intelligence (AI) technologies to provide more intelligent medical diagnosis and healthcare service support for doctors and patients.
Tencent will provide AI technologies and capabilities, integrate Medopad’s mobile health applications, and develop an AI-assisted diagnostic system for clinical decision support, medical consultation and knowledge-based Q&A chatbots, as well as tools for monitoring patient conditions and analyzing patient data.and provide decision support for physicians’ diagnoses, with further in-depth collaboration to be explored in the future to support clinical research.。
As one of the earliest and most effective countries in implementing tiered diagnosis and treatment, the United Kingdom also faces substantial medical demands from a large patient population and an increasingly heavy healthcare burden. Leveraging AI technologies to enhance the overall efficiency of the healthcare system has emerged as a key solution. Amid the global wave of artificial intelligence, “AI + Healthcare” has become a prominent focus, gradually facilitating the transformation of traditional healthcare models at the productivity level, improving the efficiency of medical services, and painting a promising blueprint for the future of healthcare.
Tencent has been conducting technological research and accumulating expertise in the field of artificial intelligence (AI) since 2012, addressing core challenges within the AI domain. As one of the first members selected for China’s “National Team” for artificial intelligence, Tencent is continuously increasing its investment in the application of medical AI across a broader range of scenarios, expanding from the domestic market to the global stage by exporting its AI capabilities overseas. “This collaboration with the UK-based mobile health companyMedopad“The collaboration will integrate the strengths of both parties in mobile health and AI technology to create world-class medical AI solutions,” said Ding Ke, Vice President of Tencent. “Meanwhile, Tencent Medical AI’s development model of simultaneous expansion in China and internationally helps us draw on the latest cutting-edge technological trends abroad and mature overseas healthcare system models, thereby exploring breakthroughs in leveraging artificial intelligence to improve tiered diagnosis and treatment and enhance the efficiency of medical services in China.”
“Tencent Medical AI Laboratory conducts research in multiple areas, including medical diagnostic reasoning engines, medical natural language processing, medical multimodal analysis, and human-computer interaction dialogue. It collaborates with numerous leading medical institutions both domestically and internationally to develop clinical decision support systems targeting high-incidence and frequently misdiagnosed conditions, as well as complex medical issues,” said Dr. Fan Wei, Head of Tencent Medical AI Laboratory.
Medopad is a London-based mobile health company that provides patient monitoring and mHealth solutions to healthcare institutions, pharmaceutical companies, insurance providers, and governments. By leveraging mobile application technologies, Medopad helps physicians enhance their diagnostic capabilities and deliver better patient care. Dan Vahdat, Co-founder and CEO of Medopad, stated, “We are delighted to partner with technology giants like Tencent, applying UK clinical expertise to develop patient-centric, innovative healthcare solutions. Furthermore, AI can help the National Health Service (NHS) medical colleges in the UK enhance clinical professional skills, thereby benefiting more patients in the UK and around the world.”
It is reported that Tencent and Medopad will jointly explore the clinical applications of AI technology to provide more intelligent medical diagnosis and healthcare support for doctors and patients. Tencent will contribute its AI technologies and capabilities, integrating them with Medopad’s mobile health applications to develop an AI-powered chatbot for clinical decision support. This tool will monitor patient conditions, analyze patient data, and offer decision-making assistance to physicians in diagnosis. In the future, the two companies plan to deepen their collaboration by further exploring support for clinical research.